SCHEMBL7499633

SCHEMBL7499633

CCOC(=O)c1ccc(CN2CCCCC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.60
LMNA P02545 2/20 0.60
MAPK1 P28482 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
MAPT P10636 1/20 0.60
TSHR P16473 1/20 0.60
STAT3 P40763 1/20 0.60
KDM4E B2RXH2 1/20 0.59
HRH3 Q9Y5N1 6/20 0.57
KCNH2 Q12809 1/20 0.57
NPC1 O15118 2/20 0.57
ALDH1A1 P00352 2/20 0.57
HDAC1 Q13547 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HPGD P15428 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10397560 0.98 RAB9A (0.62) RAB9ALMNAMAPK1SMN1; SMN2MAPT
SCHEMBL345054 0.88 TSHR (0.60) RAB9ALMNAMAPK1SMN1; SMN2MAPT
SCHEMBL347958 0.87 CHKA (0.62) RAB9ALMNAMAPK1SMN1; SMN2MAPT
SCHEMBL10568920 0.85 LMNA (0.58) RAB9ALMNAMAPK1SMN1; SMN2MAPT
SCHEMBL10397057 0.85 SMN1; SMN2 (0.80) RAB9ALMNAMAPK1SMN1; SMN2MAPT
SCHEMBL1335735 0.84 CHKA (0.71) LMNAMAPK1SMN1; SMN2MAPTKDM4E
SCHEMBL228900 0.84 CHKA (0.71) LMNAMAPK1SMN1; SMN2MAPTKDM4E
SCHEMBL24673257 0.84 LMNA (0.57) RAB9ALMNAMAPK1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL10898517 0.84 LMNA (0.57) RAB9ALMNAMAPK1SMN1; SMN2MAPT
SCHEMBL17069928 0.84 HRH3 (0.52) KDM4EHRH3ALDH1A1HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009155209-A1 OPHTHALMIC FORMULATION OF RHO KINASE INHIBITOR COMPOUND INSPIRE PHARMACEUTICALS, INC. (US) 2009-12-23 WO disclosed
EP-1171122-A4 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2002-05-29 EP disclosed
EP-1171122-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2002-01-16 EP disclosed
US-6248755-B1 ANTIINFLAMMATORY AGENTS; ANTIALLERGENS; AUTOIMMUNE DISEASES MERCK & CO., INC. 2001-06-19 US disclosed
WO-2000059502-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed
US-4910206-A Endotoxin induced lung injury SANDOZ PHARMACEUTICALS CORP. (US) 1990-03-20 US disclosed